(Q24244905)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16437496%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

review article

1 reference

title

Drug treatment for myotonia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16437496%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16437496%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

author name string

C G Faber

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16437496%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

J Trip

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16437496%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

B G M van Engelen

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16437496%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

publication date

25 January 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16437496%20AND%20SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

16 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16437496%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16437496%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

page(s)

CD004762

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16437496%20AND%20SRC:MED&resulttype=core&format=json

Effect of clomipramine on myotonia: a placebo-controlled, double-blind, crossover trial

16 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

A comparative study of disopyramide and procainamide in the treatment of myotonia in myotonic dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

Nifedipine in the treatment of myotonia in myotonic dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

The treatment of myotonia: a controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

Therapy of myotonia;: A double-blind evaluation of diphenylhydantoin, procainamide, and placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

Clinical and electrophysiological observations in patients with myotonic muscle disease and the therapeutic effect of N-propyl-ajmalin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

The depression of myotonic dystrophy: response to imipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

Taurine and hyperexcitable human muscle: effects of taurine on potassium-induced hyperexcitability of dystrophic myotonic and normal muscles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

The treatment of dystrophia myotonica with A.C.T.H.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

Procaine amide in the treatment of myotonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

Effects of acetazolamide on myotonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

Baclofen trial in six myotonic dystrophy patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

Response to treatment with antihistamines in a family with myotonia congenita

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

Antimyotonic therapy with tocainide under ECG control in the myotonic dystrophy of Curschmann-Steinert.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

Dehydroepiandrosterone for myotonic dystrophy type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

Successuful treatment of paramyotonia congenita (Eulenburg): muscle stiffness and weakness prevented by tocainide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

Creatine monohydrate in DM2/PROMM: a double-blind placebo-controlled clinical study. Proximal myotonic myopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

Paramyotonia congenita: successful treatment with tocainide. Clinical and electrophysiologic findings in seven patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

Creatine monohydrate supplementation does not increase muscle strength, lean body mass, or muscle phosphocreatine in patients with myotonic dystrophy type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

Creatine monohydrate in myotonic dystrophy: a double-blind, placebo-controlled clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

Myotonia congenita in northern Finland: an epidemiological and genetic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

Myocytes from congenital myotonic dystrophy display abnormal Na+ channel activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

Propagation disturbance of motor unit action potentials during transient paresis in generalized myotonia: a high-density surface EMG study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

Cardiac side effects of phenytoin and carbamazepine. A dose-related phenomenon?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

Population frequencies of inherited neuromuscular diseases—A world survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

Hyperkalemic periodic paralysis and the adult muscle sodium channel alpha-subunit gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

Diseases caused by voltage-gated ion channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

Molecular basis of Thomsen's disease (autosomal dominant myotonia congenita).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

Anticipation in myotonic dystrophy: fact or fiction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

The skeletal muscle chloride channel in dominant and recessive human myotonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

Human sodium channel myotonia: slowed channel inactivation due to substitutions for a glycine within the III-IV linker

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

Leukocyte CTG repeat length correlates with severity of myotonia in myotonic dystrophy type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

Therapy in myotonic disorders and in muscle channelopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

Proximal myotonic myopathy: mini-review of a recently delineated clinical disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

Founder mutations and the high prevalence of myotonia congenita in northern Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

Novel muscle chloride channel (CLCN1) mutations in myotonia congenita with various modes of inheritance including incomplete dominance and penetrance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

Sodium channel mutations in acetazolamide-responsive myotonia congenita, paramyotonia congenita, and hyperkalemic periodic paralysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

The familial periodic paralyses and nondystrophic myotonias

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

Transient muscular weakness in severe recessive myotonia congenita. Improvement of isometric muscle force by drugs relieving myotomic stiffness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

Myotonic dystrophy and proximal myotonic myophathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

Paramyotonia, potassium-aggravated myotonias and periodic paralyses. 37th ENMC International Workshop, Naarden, The Netherlands, 8-10 December 1995.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

Quantitative myotonia assessment: an experimental protocol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

Procainamide-associated pancytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

Successful treatment with tocainide of recessive generalized congenital myotonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

Tonische Krämpfe in willkürlich beweglichen Muskeln in Folge von ererbter psychischer Disposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

Agranulocytosis following procainamide administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

7 January 2021

Myotonia fluctuans. A third type of muscle sodium channel disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

7 January 2021

Procainamide-induced agranulocytosis with reversible myeloid sensitivity

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

7 January 2021

Quantitative analysis of the "warm-up" phenomenon in myotonic dystrophy type 1

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

7 January 2021

Adynamia episodica hereditaria with myotonia: a non-inactivating sodium current and the effect of extracellular pH

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

7 January 2021

Membrane defects in paramyotonia congenita (Eulenburg)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

7 January 2021

Altered Na+ channel activity and reduced Cl? conductance cause hyperexcitability in recessive generalized myotonia (becker)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

7 January 2021

Paramyotonia congenita: abnormal short exercise test, and improvement after mexiletine therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

7 January 2021

Improved therapy of myotonia with the lidocaine derivative tocainide

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

7 January 2021

Über familiäre atrophische Myotonie

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

7 January 2021

The Schwartz-Jampel syndrome. Its clinical, physiological and histological expressions

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

7 January 2021

Unstable DNA sequence in myotonic dystrophy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

7 January 2021

Treatment in myotonia and periodic paralysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

7 January 2021

Letter: Effect of baclofen on myotonia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

7 January 2021

Treatment of paramyotonia congenita with acetazolamide

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

7 January 2021

A pilot controlled study of the use of imipramine to reduce myotonia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

7 January 2021

Myotonic dystrophy treated with selenium and vitamin E

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

7 January 2021

Effect of sodium selenite and vitamin E treatment in myotonic dystrophy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

7 January 2021

Functional deterioration and selenium-vitamin E treatment in myotonic dystrophy. A placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

7 January 2021

Treatment of myotonia with antiarrhythmic drugs

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

7 January 2021

Clinical and electrophysiological reports in a case of early onset myotonia congenita (Thomsen's disease) successfully treated with mexiletine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

7 January 2021

Carbamazepine versus Diphenylhydantoin in the Treatment of Myotonia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

7 January 2021

Metabolic and clinical response to recombinant human insulin-like growth factor I in myotonic dystrophy--a clinical research center study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

7 January 2021

Efficacy of propafenone in paramyotonia congenita

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

7 January 2021

The treatment of myotonia: Evaluation of chronic oral taurine therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

7 January 2021

Randomized controlled trial of testosterone in myotonic dystrophy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

7 January 2021

Myotonia and the muscle chloride channel: dominant mutations show variable penetrance and founder effect

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

7 January 2021

A pilot study of dehydroepiandrosterone sulfate in myotonic dystrophy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004762.PUB2

7 January 2021

10.1002/14651858.CD004762.PUB2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16437496%20AND%20SRC:MED&resulttype=core&format=json

release_bxz5bk6nifbyvjluuxhvvljlv4

16 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bxz5bk6nifbyvjluuxhvvljlv4

24 November 2022

mapped directly with Wikidata item

1 reference

https://api.fatcat.wiki/v0/release/bxz5bk6nifbyvjluuxhvvljlv4

24 November 2022

mapped directly with Wikidata item

1 reference